acalabrutinib
astrazeneca
['leusm', 'acalabrutinib', 'cll']
acalabrutinib has tolerable safety profile in older, frail cll population #eha2023 #leusm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.